The American College of Medical Genetics and Genomics has appointed David Flannery to medical director. Flannery is board-certified in both clinical genetics and pediatrics, and he joins ACMG from the Medical College of Georgia where he served in a variety of clinical, academic, and medical staff leadership positions since 1984, including professor of pediatrics and chief of the genetics division. He is a founding fellow of ACMG and he is currently the ACMG representative to the American Medical Association's CPT Advisory Committee. He has also served as a member of the Southeast Regional Newborn Screening & Genetics Collaboratives.
MolecularHealth has added two new members to its US executive team: Tim Cooley and Kevin Krenzke.
Cooley will be senior VP of IT at MolecularHealth. He previously spent 15 years at Eli Lilly, where he held various positions, including director of IT. Krenzke will be senior VP of finance at MolecularHealth. He joins the firm after holding leadership roles at McKesson Specialty Health and US Oncology.
The new additions to the MolecularHealth team come as the company is readying to launch in the first quarter its TreatmentMap next-gen sequencing-based tests to guide cancer treatment.